91 related articles for article (PubMed ID: 25351809)
1. Facile preparation of a pH-sensitive nano-magnetic targeted system to deliver doxorubicin to tumor tissues.
Wu J; Xu S; Jiang W; Shen Y; Pu M
Biotechnol Lett; 2015 Mar; 37(3):585-91. PubMed ID: 25351809
[TBL] [Abstract][Full Text] [Related]
2. High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy.
Peng N; Wu B; Wang L; He W; Ai Z; Zhang X; Wang Y; Fan L; Ye Q
Biomater Sci; 2016 Nov; 4(12):1802-1813. PubMed ID: 27792228
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
Elbialy NS; Fathy MM; Khalil WM
Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterisation of a pH-sensitive magnetic nanocomposite for controlled delivery of doxorubicin.
Xu SS; Wu J; Jiang W
J Microencapsul; 2015; 32(6):533-7. PubMed ID: 26289219
[TBL] [Abstract][Full Text] [Related]
7. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
[TBL] [Abstract][Full Text] [Related]
8. Efficient reduction and pH co-triggered DOX-loaded magnetic nanogel carrier using disulfide crosslinking.
Huang J; Xue Y; Cai N; Zhang H; Wen K; Luo X; Long S; Yu F
Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():41-51. PubMed ID: 25491958
[TBL] [Abstract][Full Text] [Related]
9. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
10. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
[TBL] [Abstract][Full Text] [Related]
11. Magnetic pH-responsive nanocarrier with long spacer length and high colloidal stability for controlled delivery of doxorubicin.
Pourjavadi A; Hosseini SH; Alizadeh M; Bennett C
Colloids Surf B Biointerfaces; 2014 Apr; 116():49-54. PubMed ID: 24441180
[TBL] [Abstract][Full Text] [Related]
12. Facile solvothermal synthesis of mesostructured Fe3O4/chitosan nanoparticles as delivery vehicles for pH-responsive drug delivery and magnetic resonance imaging contrast agents.
Zhao G; Wang J; Peng X; Li Y; Yuan X; Ma Y
Chem Asian J; 2014 Feb; 9(2):546-53. PubMed ID: 24259489
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
[TBL] [Abstract][Full Text] [Related]
14. SERS spectroscopic approach to study doxorubicin complexes with Fe(2+) ions and drug release from SPION-based nanocarriers.
Gautier J; Munnier E; Douziech-Eyrolles L; Paillard A; Dubois P; Chourpa I
Analyst; 2013 Nov; 138(24):7354-61. PubMed ID: 24161961
[TBL] [Abstract][Full Text] [Related]
15. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
[TBL] [Abstract][Full Text] [Related]
16. Poly(ethylene glycol)-modified PAMAM-Fe3O4-doxorubicin triads with the potential for improved therapeutic efficacy: generation-dependent increased drug loading and retention at neutral pH and increased release at acidic pH.
Nigam S; Chandra S; Newgreen DF; Bahadur D; Chen Q
Langmuir; 2014 Feb; 30(4):1004-11. PubMed ID: 24446987
[TBL] [Abstract][Full Text] [Related]
17. Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs).
Chang Y; Meng X; Zhao Y; Li K; Zhao B; Zhu M; Li Y; Chen X; Wang J
J Colloid Interface Sci; 2011 Nov; 363(1):403-9. PubMed ID: 21821262
[TBL] [Abstract][Full Text] [Related]
18. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions.
Wu L; Zou Y; Deng C; Cheng R; Meng F; Zhong Z
Biomaterials; 2013 Jul; 34(21):5262-72. PubMed ID: 23570719
[TBL] [Abstract][Full Text] [Related]
19. Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance.
Feng L; Li K; Shi X; Gao M; Liu J; Liu Z
Adv Healthc Mater; 2014 Aug; 3(8):1261-71. PubMed ID: 24652715
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.
Dong DW; Tong SW; Qi XR
J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
